Caminati M, Cegolon L, Vianello A, et al.

Title: Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response.

Citation: Expert Rev Respir Med
2019;13:1205–1212.

Country: Italy | Indication: Asthma

This is an independent study

http://tago.ca/31592700
Scan to access the publication or visit
http://tago.ca/31592700